Protara Therapeutics (TARA) Treasury Shares (2013 - 2025)
Protara Therapeutics' (TARA) quarterly Treasury Shares came in at $571145.0 in Q4 2025, up 93.01% year-on-year from $295914.0 in Q4 2024, and up 2.86% on a QoQ basis from $555245.0 in Q3 2025.
Protara Therapeutics (TARA) Treasury Shares (2013 - 2025) Analysis & Trends
Protara Therapeutics (TARA) has 6 years of Treasury Shares data on file, last reported at $571145.0 in Q4 2025.
- On a quarterly basis, Treasury Shares rose 93.01% year-over-year to $571145.0 in Q4 2025; TTM through Dec 2025 was $571145.0, a 93.01% increase from a year earlier, with the FY2025 full-year figure at $571145.0, up 93.01% from the prior year.
- Treasury Shares for Q4 2025 stood at $571145.0, up from $555245.0 in the prior quarter.
- Over the last five years, Treasury Shares for TARA reached as high as $571145.0 in Q4 2025 and fell as low as $196838.0 in Q4 2022.
- Historically, Treasury Shares has averaged $368608.2 across 4 years, with a median of $319404.5 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 93.01% in 2025 and fell as far as 12.16% in 2025.
- Year by year, Treasury Shares stood at $196838.0 in 2022, then rose by 20.24% to $236679.0 in 2023, then grew by 25.03% to $295914.0 in 2024, then jumped by 93.01% to $571145.0 in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $571145.0 in Q4 2025, $555245.0 in Q3 2025, and $510945.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | Protara Therapeutics | 233.61 Mn | 233.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 571,145.00 |
| Dec 31, 2025 | 571,145.00 |
| Sep 30, 2025 | 555,245.00 |
| Sep 30, 2025 | 555,245.00 |
| Jun 30, 2025 | 510,945.00 |
| Jun 30, 2025 | 510,945.00 |
| Mar 31, 2025 | 384,593.00 |
| Mar 31, 2025 | 384,593.00 |
| Dec 31, 2024 | 295,914.00 |
| Dec 31, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Sep 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Jun 30, 2024 | 295,914.00 |
| Mar 31, 2024 | 342,895.00 |
| Mar 31, 2024 | 342,895.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2023 | 236,679.00 |
| Dec 31, 2022 | 196,838.00 |
| Dec 31, 2022 | 196,838.00 |